Vice President, Global Commercial Strategy
Current• Leading the Global Commercial Strategy team, including two Directors and a Senior Manager, reporting into the Chief Commercial Officer (CCO). • Oversight of commercially focused collaborations with our pharmaceutical and biotech partnerships with Boehringer Ingelheim (CT-155, CT-156), Indivior (CT-102), and Otsuka Precision Health (Rejoyn). • Leading the commercial aspects for Click Therapeutics within the cross-functional joint asset teams (JAT) for the Boehringer Ingelheim and Indivior collaborations.• Collaborating with the Business Development team on inbound and outbound interest in digital therapeutics programs with various pharmaceutical and biotech companies.• Establishing commercial due diligence and business cases for inbound and outbound business development opportunities. • Leading internal strategy and discussions around Click Therapeutics’ DiNaMo program, which focuses on establishing proof of concept for the role of prescription digital therapeutics across therapeutic areas. • Assessing potential go-to-market and portfolio opportunities for our in-development and pipeline assets. • Co-Chair on the Digital Therapeutics Alliance’s Integration & Workflow working group (April 2023 – September 2024).